Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Thoracic Malignancies
•
Thoracic Surgery
How do you decide which local consolidative therapy to offer for a single lung metastasis in a patient with metastatic colorectal cancer?
(ie. surgery vs SBRT)
Answer from: Radiation Oncologist at Community Practice
SBRT, then more chemotherapy.
Sign in or Register to read more
6461
Related Questions
Would you hold CGRP (calcitonin gene-related peptide) monoclonal antibodies such as Eptinezumab-jjmr (Vyepti) before, during, or after lung SBRT?
How do you define treatment volumes for patients treated with neoadjuvant chemoimmunotherapy for resectable NSCLC who are no longer surgical candidates or decline surgery?
Would you offer postoperative radiation for a patient who initially had biopsy-proven multistation N2 NSCLC but had a nodal pCR upon surgical resection+ LND after neoadjuvant chemo-immunotherapy?
How would you approach a localized but unresectable adenoid cystic carcinoma of the distal trachea?
In oligometastatic NSCLC with a solitary brain metastasis and lung primary amenable to SBRT, how would you sequence first-line systemic therapy versus local therapy to the lung after treatment of the CNS metastasis?
What systemic therapy would you offer to a patient with metastatic EGFR exon 19 deleted NSCLC to the brain with isolated CNS progression while on osimertinib 80 mg and progressed through WBRT?
What ipsilateral lung constraints if any do you utilize for SBRT and or hypofractionated RT in the lungs?
Would you give RT to a young BAP1+ patient with lung cancer s/p NAC and P/D who has biopsy-proven pleural recurrence after adjuvant chemo?
Would you offer definitive CRT for stage III(N3) NSCLC treated with neoadjuvant immunotherapy who had a complete radiographic response?
How often, if ever, do patients with initially negative targetable mutation workup become positive later in recurrent lung cancer?